SuspensionMRP Under Process
Official PMBI MRP is being updated for catalog code 2517.
Locate Jan Aushadhi KendraClinical Overview
Citicoline (Cytidine 5'-diphosphocholine / CDP-Choline) is a physiological intermediate in the biosynthesis of phosphatidylcholine, the major phospholipid component of neuronal membranes. It repairs damaged neuronal membranes, accelerates reabsorption of cerebral edema, inhibits free fatty acid release, and promotes acetylcholine and dopamine synthesis in the brain. Indicated for acute and subacute ischemic stroke recovery, traumatic brain injury (TBI), cognitive impairment, and vascular dementia.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with water, divided throughout the day, with or between meals. Follow prescribed treatment duration.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Insomnia, headache, diarrhea, low blood pressure, nausea, blurred vision, flushing. Rare/Severe: Marked hypotension and severe bradycardia or tachycardia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Caution in patients with persistent intracranial bleeding; avoid high parenteral doses (> 1000 mg/day). May cause transient hypotension.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Citicoline Tablets 500mg
Citicoline (Cytidine 5'-diphosphocholine / CDP-Choline) is a physiological intermediate in the biosynthesis of phosphatidylcholine, the major phospholipid component of neuronal membranes. It repairs damaged neuronal membranes, accelerates reabsorption of cerebral edema, inhibits free fatty acid release, and promotes acetylcholine and dopamine synthesis in the brain. Indicated for acute and subacute ischemic stroke recovery, traumatic brain injury (TBI), cognitive impairment, and vascular dementia.
Citicoline 500mg + Piracetam 800mg Tablets
Citicoline and Piracetam is a synergistic neuroprotective and nootropic formulation. Citicoline serves as an essential intermediate in the biosynthesis of structural neuronal membrane phosphatidylcholine and raises brain acetylcholine and dopamine levels, while piracetam, a cyclic GABA derivative, allosterically modulates AMPA receptors, improves erythrocyte deformability, enhances microvascular cerebral blood flow, and elevates neuronal ATP turnover. Indicated for cognitive dysfunction, acute ischemic stroke recovery, vascular dementia, post-concussion syndrome, and senile memory impairment.
Citicoline Injection 250mg per ml
Citicoline (Cytidine 5'-diphosphocholine / CDP-Choline) is a physiological intermediate in the biosynthesis of phosphatidylcholine, the major phospholipid component of neuronal membranes. It repairs damaged neuronal membranes, accelerates reabsorption of cerebral edema, inhibits free fatty acid release, and promotes acetylcholine and dopamine synthesis in the brain. Indicated for acute and subacute ischemic stroke recovery, traumatic brain injury (TBI), cognitive impairment, and vascular dementia.